Melissa J Naylor, NP

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Melissa J Naylor’s office at (650) 723-4000 to ask if they take your plan before you enroll.

California Medical Board record

Licence C18778 · Cancelled

Licence status: Cancelled · since 1957 · University of Kansas School of Medicine.

License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.

Matched on the licence number without its letter prefix; check the name before relying on it.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Stanford Health Care

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	5.31 (4.24 to 6.37) · 8,661 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	14.1 (12.7 to 15.7) · 2,191 cases	Worse	Jan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths	4.08 (1.95 to 6.21) · 5,296 cases	Better	Jul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.317	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.446	Better	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.241	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.7 (0.6 to 0.9) · 3,348 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.06 (0.45 to 1.67) · 5,374 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.86 (0.72 to 1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	166.09 (137.88 to 194.3) · 470 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.1 · 192 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6.4 · 146 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	9.7 · 253 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.3 · 880 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 935 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	8.7 · 501 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.1 · 7,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.13 (0 to 0.27) · 20,799 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.14 to 0.43) · 23,182 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.94 (0.2 to 1.68) · 5,694 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.36 (1.54 to 3.19) · 7,846 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.2 (3.76 to 6.64) · 5,603 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.38 (0.23 to 2.53) · 2,211 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.52 (0.21 to 0.83) · 19,915 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.6 · 416 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.869	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.857	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.368	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16.2 · 247 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20.5 · 1,021 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	47.8 · 258 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-1.6 · 990 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	20.8 · 976 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.5 · 959 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (4.4 to 6.2) · 2,191 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.1 · 425 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	9.6 · 158 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	19.6 · 183 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.7 (10.4 to 15.4) · 4,578 cases	No different	Jan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at Stanford Health Care

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at Stanford Health Care

Room was "always" clean	75%
Nurses "always" communicated well	82%
Doctors "always" communicated well	81%
Staff "always" explained	63%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	89%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	79%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	83%
Staff "always" explained possible side effects	50%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$50,196

Medicare paid this office $50,196 for 221 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Long return visit (40+ min)	116	$27,790	$137
Return visit (30+ min)	70	$9,457	$94
Long return visit (40+ min)	38	$5,969	$103
Telephone medical discussion with physician, 21-30 minutes	17	$2,423	$105
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	33	$1,159	$25

See all 7 services

Sort by

Every Original Medicare service billed

Long return visit (40+ min)	116	$27,790	$137
Return visit (30+ min)	70	$9,457	$94
Long return visit (40+ min)	38	$5,969	$103
Telephone medical discussion with physician, 21-30 minutes	17	$2,423	$105
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	33	$1,159	$25
Return visit (30+ min)	16	$1,064	$63
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	14	$288	$19

Who their Medicare patients are

221 Original Medicare patients in 2024. Average age 71 · Under 65 17% · 85 and older 10% · Women 62% · Also on Medicaid 41% · Health risk score 2.19. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 73% · Diabetes 56% · Chronic kidney disease 36% · Coronary heart disease 27% · Atrial fibrillation 23% · Depression 23% · Heart failure 21% · Cancer 19% · COPD 14% · Stroke 10% · Dementia 6%.

The office billed $319,234, Medicare allowed $67,893 and paid $50,196; for 488 services of 10 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	221	488	71	2.19	$319,234	$50,196
2023	190	409	71	2.00	$270,982	$34,727
2022	199	423	70	1.97	$273,651	$34,230
2021	79	193	70	2.06	$136,463	$18,309
2020	54	69	67	2.05	$27,842	$4,567
2019	69	92	71	2.00	$11,087	$5,904
2018	71	109	69	2.20	$9,567	$6,012
2017	37	45	64	2.84	$5,303	$2,109
2016	17	22	64	1.81	$4,359	$1,187
2015	27	30	68	1.41	$8,419	$2,351
2014	12	12	63	2.46	$2,187	$677

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 4 services

Sort by

Original Medicare services billed in 2023

Long return visit (40+ min)	122	$24,809	$106
Return visit (30+ min)	68	$5,899	$63
Telephone medical discussion with physician, 21-30 minutes	22	$1,915	$66
Telephone medical discussion with physician, 11-20 minutes	16	$985	$49

2022: 5 services

Sort by

Original Medicare services billed in 2022

Long return visit (40+ min)	142	$22,721	$101
Return visit (30+ min)	54	$4,876	$73
Telephone medical discussion with physician, 21-30 minutes	28	$2,728	$68
Telephone medical discussion with physician, 11-20 minutes	27	$1,346	$43
Short return visit (20+ min)	18	$892	$42

2021: 4 services

Sort by

Original Medicare services billed in 2021

Long return visit (40+ min)	50	$11,386	$114
Return visit (30+ min)	22	$2,134	$79
Telephone medical discussion with physician, 21-30 minutes	20	$2,039	$68
New patient visit (60+ min)	15	$1,740	$116

2020: 2 services

Sort by

Original Medicare services billed in 2020

Long return visit (40+ min)	21	$1,441	$69
Return visit (30+ min)	18	$1,259	$60

2019: 2 services

Sort by

Original Medicare services billed in 2019

Long return visit (40+ min)	24	$2,661	$83
Return visit (30+ min)	39	$2,501	$56

2018: 3 services

Sort by

Original Medicare services billed in 2018

Return visit (30+ min)	44	$2,789	$58
Long return visit (40+ min)	12	$1,696	$85
Short return visit (20+ min)	34	$1,449	$37

2017: 2 services

Sort by

Original Medicare services billed in 2017

Short return visit (20+ min)	24	$931	$37
Return visit (30+ min)	12	$660	$55

Drugs they prescribed that Part D paid

$445,966

Pharmacies billed $445,966 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 972) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.

361 generic and 517 brand-name prescriptions · $445,966 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Ozempic	89	$94,583	$1,063
Mounjaro	54	$80,655	$1,494
Tymlos	27	$69,140	$2,561
Trulicity	49	$54,365	$1,109
Jardiance	16	$20,116	$1,257

See all 26 drugs

Sort by

Every Part D drug this clinician prescribed

Ozempic	89	$94,583	$1,063
Mounjaro	54	$80,655	$1,494
Tymlos	27	$69,140	$2,561
Trulicity	49	$54,365	$1,109
Jardiance	16	$20,116	$1,257
Basaglar Kwikpen U-100	22	$7,745	$352
Tresiba Flextouch U-200	12	$7,597	$633
Tirosint	20	$2,962	$148
Ultra-Fine Mini Pen Needle	26	$2,687	$103
Lantus Solostar	23	$2,428	$106
Nano 2nd Gen Pen Needle	22	$2,375	$108
Humalog Kwikpen U-100	11	$1,611	$146
Synthroid	30	$1,572	$52
Comfort Ez Pen Needle	13	$1,210	$93
Levothyroxine	117	$1,209	$10
Ultra-Fine Nano Pen Needle	17	$1,143	$67
Ezetimibe	16	$633	$40
Levoxyl	12	$604	$50
Methimazole	33	$348	$11
Hydrocortisone	15	$314	$21
Glipizide	47	$311	$7
Repaglinide	21	$233	$11
Metformin	28	$209	$7
Rosuvastatin	16	$208	$13
Metformin Hcl Er	17	$162	$10
Alendronate	16	$65	$4

Year by year

Sort by

Part D prescribing by year

2024	972	146	0% (0)	53%	$445,966
2023	822	115	0% (0)	51%	$485,334
2022	819	124	0% (0)	54%	$428,711
2021	507	77	0% (0)	57%	$274,129
2020	266	54	0% (0)	60%	$126,617
2019	307	50	0% (0)	48%	$88,797
2018	138	40	0% (0)	36%	$43,233
2017	26	14	0% (0)	62%	$9,750
2016	96	31	0% (0)	56%	$46,482
2015	103	39	0% (0)	66%	$44,273
2014	74	30	None	70%	$29,369
2013	47	19	23% (11)	51%	$11,050

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 26 drugs

Sort by

Part D drugs prescribed in 2023

Trulicity	62	$86,778	$1,400
Tymlos	23	$73,545	$3,198
Ozempic	54	$70,124	$1,299
Humalog Kwikpen U-200	21	$48,491	$2,309
Jardiance	15	$21,525	$1,435
Tresiba Flextouch U-200	16	$17,942	$1,121
Victoza 3-Pak	12	$16,195	$1,350
Lantus Solostar	31	$15,023	$485
Rybelsus	13	$13,815	$1,063
Novolog Flexpen	15	$12,778	$852
Basaglar Kwikpen U-100	13	$5,346	$411
Ultra-Fine Mini Pen Needle	22	$3,287	$149
Nano 2nd Gen Pen Needle	15	$1,997	$133
Comfort Ez Pen Needle	17	$1,876	$110
Levothyroxine	84	$1,555	$19
Synthroid	15	$1,037	$69
Levoxyl	13	$641	$49
Ezetimibe	14	$484	$35
Methimazole	26	$461	$18
Metformin	30	$420	$14
Alendronate	37	$387	$10
Metformin Hcl Er	15	$368	$25
Repaglinide	25	$337	$13
Atorvastatin	21	$260	$12
Rosuvastatin	11	$238	$22
Glipizide	28	$209	$7

2022: 20 drugs

Sort by

Part D drugs prescribed in 2022

Trulicity	107	$141,764	$1,325
Humalog Kwikpen U-200	17	$37,915	$2,230
Tymlos	12	$28,987	$2,416
Lantus Solostar	50	$28,179	$564
Ozempic	14	$24,554	$1,754
Novolog Flexpen	13	$17,094	$1,315
Humalog Kwikpen U-100	20	$15,663	$783
Tresiba Flextouch U-200	19	$12,559	$661
Ultra-Fine Mini Pen Needle	27	$3,680	$136
Nano 2nd Gen Pen Needle	18	$1,759	$98
Levothyroxine	73	$1,211	$17
Synthroid	20	$1,069	$53
Repaglinide	35	$703	$20
Methimazole	40	$508	$13
Glipizide	38	$319	$8
Levoxyl	13	$260	$20
Metformin	17	$159	$9
Alendronate	24	$74	$3
Atorvastatin	16	$61	$4
Alcohol Prep Pads	11	$23	$2

2021: 15 drugs

Sort by

Part D drugs prescribed in 2021

Trulicity	79	$99,860	$1,264
Lantus Solostar	34	$22,555	$663
Novolog Flexpen	18	$20,115	$1,117
Humalog Kwikpen U-200	11	$15,706	$1,428
Jardiance	11	$13,303	$1,209
Lantus	11	$9,130	$830
Toujeo Solostar	13	$5,224	$402
Ultra-Fine Mini Pen Needle	20	$2,420	$121
Nano 2nd Gen Pen Needle	18	$1,357	$75
Levothyroxine	22	$398	$18
Methimazole	27	$245	$9
Repaglinide	11	$235	$21
Metformin	16	$159	$10
Glipizide	21	$115	$5
Alcohol Prep Pads	11	$24	$2

2020: 6 drugs

Sort by

Part D drugs prescribed in 2020

Trulicity	58	$73,728	$1,271
Lantus Solostar	14	$6,981	$499
Levothyroxine	22	$476	$22
Methimazole	26	$198	$8
Glipizide	11	$124	$11
Alcohol Prep Pads	12	$27	$2

2019: 9 drugs

Sort by

Part D drugs prescribed in 2019

Trulicity	25	$24,885	$995
Humalog Kwikpen U-100	12	$7,933	$661
Lantus Solostar	14	$6,273	$448
Humalog Mix 75-25	11	$4,608	$419
Lantus	11	$3,104	$282
Levothyroxine	40	$859	$21
Testosterone Cypionate	16	$461	$29
Methimazole	22	$155	$7
Glipizide	13	$110	$8

2018: 2 drugs

Sort by

Part D drugs prescribed in 2018

Levothyroxine	14	$372	$27
Easy Touch Alcohol Prep Pads	13	$54	$4

2016: 1 drug

Sort by

Part D drugs prescribed in 2016

Humulin R U-500	13	$17,292	$1,330

2015: 2 drugs

Sort by

Part D drugs prescribed in 2015

Novolog Flexpen	11	$7,563	$688
Humalog	15	$6,393	$426

2014: 1 drug

Sort by

Part D drugs prescribed in 2014

Humalog	25	$14,784	$591

2013: 1 drug

Sort by

Part D drugs prescribed in 2013

Hydrocodone-Acetaminophen	11	$101	$9

Money from drug and device companies

$3,411 in 2025

Sort by

Industry payments by year

2025	11	18	None	$3,411
2024	5	5	None	$411
2023	3	4	None	$429
2022	3	5	None	$362
2021	1	1	None	$122

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Amgen	None	$1,921	6 payments Travel · 2025-04-08 · $238 Meals · 2025-04-08 · $57 Travel · 2025-04-07 · $405 Travel · 2025-04-07 · $238 Travel · 2025-04-07 · $865 Meals · 2025-04-07 · $119
Medtronic	Minimed 780g	$254	2 payments Meals for Minimed 780g · 2025-11-18 · $147 Meals for Minimed 780g · 2025-08-28 · $106
Radius Health	Tymlos	$219	2 payments Meals for Tymlos · 2025-10-09 · $123 Meals for Tymlos · 2025-04-29 · $96
Abbott Laboratories	Freestyle Libre 3	$176	1 payment Meals for Freestyle Libre 3 · 2025-05-13 · $176
Dexcom	Dexcom G6 Transmitter	$153	1 payment Meals for Dexcom G6 Transmitter · 2025-10-23 · $153
Insulet	Omnipod	$149	1 payment Meals for Omnipod · 2025-10-30 · $149

See all 18 published payments

Sort by

Every published payment

Beta Bionics	Meals · 2025-12-29	Ilet Bionic Pancreas	$121
Medtronic	Meals · 2025-11-18	Minimed 780g	$147
Lilly USA	Meals · 2025-11-05	Mounjaro	$115
Insulet	Meals · 2025-10-30	Omnipod	$149
Dexcom	Meals · 2025-10-23	Dexcom G6 Transmitter	$153
Mannkind	Meals · 2025-10-22	Afrezza	$47
Radius Health	Meals · 2025-10-09	Tymlos	$123
Sequel Med Tech	Meals · 2025-09-15	Twiist	$145
Medtronic	Meals · 2025-08-28	Minimed 780g	$106
Novo Nordisk	Meals · 2025-08-20	Ozempic	$111
Abbott Laboratories	Meals · 2025-05-13	Freestyle Libre 3	$176
Radius Health	Meals · 2025-04-29	Tymlos	$96
Amgen	Travel · 2025-04-08	None	$238
Amgen	Meals · 2025-04-08	None	$57
Amgen	Travel · 2025-04-07	None	$405
Amgen	Travel · 2025-04-07	None	$238
Amgen	Travel · 2025-04-07	None	$865
Amgen	Meals · 2025-04-07	None	$119

See earlier years (2024, 2023, 2022, 2021)

2024: $411

Sort by

Payments by company in 2024

Abbott Laboratories	Freestyle Libre 3	$133	1 payment Meals for Freestyle Libre 3 · 2024-01-29 · $133
Corcept Therapeutics	Korlym	$119	1 payment Meals for Korlym · 2024-10-18 · $119
Radius Health	Tymlos	$113	1 payment Meals for Tymlos · 2024-11-13 · $113
Abbvie	None	$30	1 payment Meals · 2024-05-09 · $30
Revance Therapeutics	Daxxify	$16	1 payment Meals for Daxxify · 2024-05-22 · $16

2023: $429

Sort by

Payments by company in 2023

Abbott Laboratories	Freestyle Libre 3	$157	2 payments Meals for Freestyle Libre 2 · 2023-04-27 · $12 Meals for Freestyle Libre 3 · 2023-04-23 · $146
MannKind	Afrezza	$150	1 payment Meals for Afrezza · 2023-05-06 · $150
Dexcom	Dexcom G7 Gss (161)	$122	1 payment Meals for Dexcom G7 Gss (161) · 2023-03-31 · $122

2022: $362

Sort by

Payments by company in 2022

Novo Nordisk	Ozempic	$198	3 payments Education · 2022-10-31 · $32 Meals for Ozempic · 2022-07-21 · $116 Meals for Ozempic · 2022-05-13 · $50
Lilly USA	Mounjaro	$116	1 payment Meals for Mounjaro · 2022-07-14 · $116
Horizon Therapeutics plc	Tepezza	$48	1 payment Meals for Tepezza · 2022-05-12 · $48

2021: $122

Sort by

Payments by company in 2021

Novo Nordisk	Rybelsus	$122	1 payment Meals for Rybelsus · 2021-10-07 · $122

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score: 76.5 / 100; Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI: 1801086764
Licence: CA 18778California C18778: Cancelled
Trained: Vanderbilt University School of Medicine, 2006
Group: Stanford Health Care
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Nurse practitioner (363L00000X); Federal specialty code 363LA2200X (363LA2200X)
Mailing address: 300 Pasteur Dr, Stanford, CA, 94305
NPI first listed: 2007-07-26
NPI last updated: 2025-12-30
NPI record certified: 2025-12-30

This is when the NPI record was last certified, not a medical board exam.